Insmed, Inc announced yesterday that the FDA had approved the use of the drug Iplex that it manufactures. Iplex is indicated for treating children with growth problems.
The drug will not be released until late 2006, but it will be used to treat children with a severe primary IGF-1 deficiency or deletion of the Growth Hormone gene.
The release of Insmed’s Iplex comes after Tecica Inc announced in late summer that the FDA had approved the use of its drug Increlex for treatment of IGF deficiency as well.
Your Comments
on Can Growth Hormone Stop Aging?
on Biogeneric Human Growth Hormone
on Can Growth Hormone Stop Aging?
on Steroids and Human Growth Hormone Scandal
on High School Athletes To Be Tested
on Steroids and Human Growth Hormone Scandal
on Biogeneric Human Growth Hormone
on Biogeneric Human Growth Hormone
on Biogeneric Human Growth Hormone
on Biogeneric Human Growth Hormone